In areas with low hepatitis B virus (HBV) endemicity such as most parts of
Europe and the United States "anti-HBc alone" is found in 10-20% of all ind
ividuals with HBV markers, i.e., 1-4% of the population. In about 10% of th
ese individuals HBV DNA is detected by PCR, the proportions varying greatly
depending on the population studied, being highest in individuals coinfect
ed with hepatitis C virus (HCV) (above 35%) and HIV (above 85%). A small pr
oportion of individuals with "anti-HBc alone" are in the window phase of an
HBV infection or in a stage of late HBV immunity. For the large proportion
of these individuals this is not the case and they are thought to have an
unresolved HBV-infection or a chronic infection in a late or "low grade" pr
oductive state. Currently, limited studies have been performed concerning t
he clinical aspects of individuals with "anti-HBc alone" and suspected chro
nic HBV infection. The majority of these individuals seem to be healthy. So
me chronic carriers with "anti-HBc alone," however, do present signs of chr
onic hepatitis. individuals with "anti-HBc alone" are potentially infectiou
s. This is exemplified by a few case reports of HBV transmission to sexual
contacts, perinatal transmission between mother and newborns and in blood r
ecipients. Recommendations are given in relation to both the diagnostic and
therapeutic procedures in the individuals with "anti-HBc alone" and in the
blood banking and transplantation services. J. Med. Virol 62:450-455, 2000
. (C) 2000 Wiley-Liss, Inc.